MedTrace Logo

Medical Expulsive Therapy for Ureter Stone Using Naftopidil

NCT01952314 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2015-12-10

No results posted yet for this study

Summary

This study is to investigate whether naftopidil is effective or not for the spontaneous passage of ureteral stones with sizes of 3 to 10 mm.

Conditions

  • Ureter Stones

Interventions

DRUG

Naftopidil 75mg

naftopidil 75mg 1T qd hs

DRUG

Placebo for Naftopidil

Placebo 1T qd hs

DRUG

Standard treatment

Aceclofenac 100mg or tramadol37.5mg/acetaminophen 325mg on demand

Sponsors & Collaborators

  • Dong-A ST Co., Ltd.

    collaborator INDUSTRY

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Chang Wook Jeong, M.D., Ph.D. · Seoul National University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2015-08-31
Completion
2015-08-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01952314 on ClinicalTrials.gov